Senate bill · 119th Congress · Latest step: Introduced
Securing America’s Drug Supply from Communist China Act
Official title: A bill to require regulatory review of pharmaceutical products from Chinese entities, and for other purposes.
Sponsor: Sen. Tom Cotton R-ARWhere it went
- IntroducedApr 16, 2026
- Committee action—
- Passed Senate—
- Passed House—
- To the President—
- Became law—
Latest action: Apr 16, 2026 — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Vote results
No recorded roll-call votes on this bill in PORKER’s records (voice votes and unanimous consent are not roll calls; roll-call records start in 2011).
Cosponsors
1 cosponsor — 1 Republican
0 of 1 cosponsors (0%) are from the other party.
More from the sponsor
Other 119th Congress bills sponsored by Sen. Tom Cotton.
- S. 4465 (119th) A bill to amend the FISA Amendments Act of 2008 to extend the authorities of title VII of the Foreign Intelligence Surveillance Act of…
- S. 1552 (119th) Living Donor Protection Act of 2025
- S. 2342 (119th) Intelligence Authorization Act for Fiscal Year 2026
- S. 4615 (119th) Intelligence Authorization Act for Fiscal Year 2027
- S.Res. 73 (119th) An original resolution authorizing expenditures by the Select Committee on Intelligence.
- S. 1793 (119th) COUNTER Act
Sponsor’s state and district
Data as of Sep 25, 2026 · bill record checked by PORKER from Congress.gov · votes from Senate.gov and the House Clerk. PORKER is non-partisan.